Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding

被引:36
|
作者
Chen, Zengsheng [1 ]
Zhang, Jiafeng [1 ]
Kareem, Kafayat [1 ]
Tran, Douglas [1 ]
Conway, Robert G. [1 ]
Arias, Katherin [1 ,2 ]
Griffith, Bartley P. [1 ]
Wu, Zhongjun J. [1 ,2 ]
机构
[1] Univ Maryland, Sch Med, Dept Surg, 10 South Pine St,MSTF 434A, Baltimore, MD 21201 USA
[2] Univ Maryland, A James Clark Sch Engn, Fischell Dept Bioengn, College Pk, MD 20742 USA
关键词
continuous flow ventricular assist device; hemostasis dysfunction; high mechanical shear stress; platelet; von Willebrand factor; VON-WILLEBRAND SYNDROME; GLYCOPROTEIN IB-ALPHA; SHEAR-STRESS; PUMP THROMBOSIS; FLOW; ACTIVATION; TIME; VI; ANTICOAGULATION; HEMOLYSIS;
D O I
10.1111/aor.13445
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Thrombotic and bleeding complications are the major obstacles for expanding mechanical circulatory support (MCS) beyond the current use. While providing the needed hemodynamic support, those devices can induce damage to blood, particularly to platelets. In this study, we investigated device-induced alteration of three major platelet surface receptors, von Willebrand factor (VWF) and associated hemostatic functions relevant to thrombosis and bleeding. Fresh human whole blood was circulated in an extracorporeal circuit with a clinical rotary blood pump (CentriMag, Abbott, Chicago, IL, USA) under the clinically relevant operating condition for 4hours. Blood samples were examined every hour for glycoprotein (GP) IIb/IIIa activation and receptor loss of GPVI and GPIb alpha on the platelet surface with flow cytometry. Soluble P-selectin in hourly collected blood samples was measured by enzyme linked immunosorbent assay to characterize platelet activation. Adhesion of device-injured platelets to fibrinogen, collagen, and VWF was quantified with fluorescent microscopy. Device-induced damage to VWF was characterized with western blotting. The CentriMag blood pump induced progressive platelet activation with blood circulating time. Particularly, GPIIb/IIIa activation increased from 1.1% (Base) to 11% (4hours) and soluble P-selectin concentration increased from 14.1ng/mL (Base) to 26.5ng/mL (4hours). Those device-activated platelets exhibited increased adhesion capacity to fibrinogen. Concurrently, the CentriMag blood pump caused progressive platelet receptor loss (GPVI and GPIb alpha) with blood circulating time. Specifically, MFI of the GPVI and GPIb alpha receptors decreased by 17.2% and 16.1% for the 4-hours sample compared to the baseline samples, respectively. The device-injured platelets exhibited reduced adhesion capacities to collagen and VWF. The high molecular weight multimers (HMWM) of VWF in the blood disappeared within the first hour of the circulation. Thereafter the multimeric patterns of VWF were stable. The change in the VWF multimeric pattern was different from the progressive structural and functional changes of platelets with the circulation time. This study suggested that the CentriMag blood pump could induce two opposite effects on platelets and associated hemostatic functions under a clinically relevant operating condition. The device-altered hemostatic function may contribute to thrombosis and bleeding simultaneously as occurring in patients supported by a rotary blood pump. Device-induced damage of platelets may be an important cause for bleeding in patients supported with rotary blood pump MCS systems relative to device-induced loss of HMWM-VWF.
引用
收藏
页码:745 / 755
页数:11
相关论文
共 45 条
  • [31] Current risks of HeartMate II pump thrombosis: Non-parametric analysis of Interagency Registry for Mechanically Assisted Circulatory Support data
    Smedira, Nicholas G.
    Blackstone, Eugene H.
    Ehrlinger, John
    Thuita, Lucy
    Pierce, Christopher D.
    Moazami, Nader
    Starling, Randall. C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (12): : 1527 - 1534
  • [32] Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the Heart Mate II left ventricular assist device
    Kirklin, James K.
    Naftel, David C.
    Kormos, Robert L.
    Pagani, Francis D.
    Myers, Susan L.
    Stevenson, Lynne W.
    Acker, Michael. A.
    Goldstein, Daniel. L.
    Silvestry, Scott C.
    Milano, Carmelo A.
    Baldwin, J. Timothy
    Pinney, Sean
    Rame, J. Eduardo
    Miller, Marissa A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (01): : 12 - 22
  • [33] Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report
    Kostos, Louise
    Burbury, Kate
    Srivastava, Gaurav
    Prince, H. Miles
    PLATELETS, 2015, 26 (08) : 809 - 811
  • [34] Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia
    Josephson, Cassandra D.
    Granger, Suzanne
    Assmann, Susan F.
    Castillejo, Marta-Ines
    Strauss, Ronald G.
    Slichter, Sherrill J.
    Steiner, Marie E.
    Journeycake, Janna M.
    Thornburg, Courtney D.
    Bussel, James
    Grabowski, Eric F.
    Neufeld, Ellis J.
    Savage, William
    Sloan, Steven R.
    BLOOD, 2012, 120 (04) : 748 - 760
  • [35] A portable pneumatic compression device to prevent venous thromboembolism in orthopedic patients with the highest risks of both venous thrombosis and bleeding: A case series study
    Takahashi, Yoshiki
    Takahira, Naonobu
    Shibuya, Manaka
    Uchiyama, Katsufumi
    Fukushima, Kensuke
    Iwase, Dai
    Kawamura, Tadashi
    Miyagi, Masayuki
    Higashiyama, Reiji
    Moriya, Mitsutoshi
    Sakai, Kenta
    Tsuda, Kouji
    Sakamoto, Miki
    Akamine, Akihiko
    Takaso, Masashi
    JOURNAL OF ORTHOPAEDIC SURGERY, 2020, 28 (01)
  • [36] Total left ventricular outflow tract obstruction due to left ventricular assist device-induced sub-aortic thrombosis in 2 patients with aortic valve bioprosthesis
    Rose, AG
    Connelly, JH
    Park, SJ
    Frazier, OH
    Miller, LW
    Ormaza, S
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (05): : 594 - 599
  • [37] Bloodstream infections in mechanical circulatory support device recipients in the International Society of Heart and Lung Transplantation Mechanically Assisted Circulation Support Registry: Epidemiology, risk factors, and mortality
    Aslam, Saima
    Xie, Rongbing
    Cowger, Jennifer
    Kirklin, James K.
    Chu, Vivian H.
    Schueler, Stephan
    de By, Theo
    Gould, Kate
    Morrissey, Orla
    Lund, Lars H.
    Martin, Stanley
    Goldstein, Daniel
    Hannan, Margaret
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (08): : 1013 - 1020
  • [38] Platelet function analyser (PFA)-100® closure time in the evaluation of non-steroidal anti-inflammatory drug-induced platelet dysfunction in children with bleeding symptoms
    Akin, Mehmet
    Polat, Yusuf
    BLOOD TRANSFUSION, 2012, 10 (04) : 545 - 546
  • [39] What is the truth behind pump thrombosis in the HeartMate II device? A National Heart, Lung, and Blood Institute perspective based on data from the Interagency Registry for Mechanically Assisted Circulatory Support
    Jeffries, Neal
    Miller, Marissa A.
    Taddei-Peters, Wendy C.
    Burke, Catherine
    Baldwin, J. Timothy
    Young, James B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (12): : 1505 - 1510
  • [40] Anti-thrombotic action of DZ-697b, a novel anti-platelet agent, on photochemically induced thrombosis with lower bleeding risk in guinea pig
    Shibutani, Tomoko
    Iijima, Takako
    Kaneda, Yuki
    Muramastu, Sumie
    Ogihara, Yoshiyasu
    Shibano, Toshiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 268P - 268P